Synaptogenix, Inc. (NASDAQ:SNPX – Get Free Report) was the recipient of a significant growth in short interest during the month of August. As of August 31st, there was short interest totalling 358,600 shares, a growth of 40.5% from the August 15th total of 255,300 shares. Approximately 3.7% of the company’s shares are sold short. Based […]
Mineralys Therapeutics (NASDAQ:MLYS – Get Free Report) and Synaptogenix (NASDAQ:SNPX – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings. Valuation and Earnings This table compares Mineralys Therapeutics […]
Bryostatin-1 from Synaptogenix Shows Statistically Significant Results as an ALS Treatment in Pre-Clinical Independent Study kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.
83.3% from the April 30th total of 13,600 shares. Based on an average daily volume of 80,000 shares, the short-interest ratio is presently 0.0 days.
The company has a market capitalization of $35.29 million and a price-to-earnings ratio of -1.13. Synaptogenix, Inc. has a 52 week low of $0.72 and
Synaptogenix, Inc. (NASDAQ:SNPX – Get Free Report) was the target of a significant decrease in short interest in the month of June. As of June 30th, there was short interest totalling 4,300 shares, a decrease of 51.7% from the June 15th total of 8,900 shares. Approximately 0.1% of the company’s shares are sold short. Based […]